Abstract:Metabolism of xenobiotics remains a central challenge for the discovery and development of drugs, cosmetics, nutritional supplements, and agrochemicals. Metabolic transformations are frequently related to the incidence of toxic effects that may result from the emergence of reactive species, the systemic accumulation of metabolites, or by induction of metabolic pathways. Experimental investigation of the metabolism of small organic molecules is particularly resource demanding; hence, computational methods are of considerable interest to complement experimental approaches. This review provides a broad overview of structure- and ligand-based computational methods for the prediction of xenobiotic metabolism. Current computational approaches to address xenobiotic metabolism are discussed from three major perspectives: (i) prediction of sites of metabolism (SOMs), (ii) elucidation of potential metabolites and their chemical structures, and (iii) prediction of direct and indirect effects of xenobiotics on metabolizing enzymes, where the focus is on the cytochrome P450 (CYP) superfamily of enzymes, the cardinal xenobiotics metabolizing enzymes. For each of these domains, a variety of approaches and their applications are systematically reviewed, including expert systems, data mining approaches, quantitative structure-activity relationships (QSARs), and machine learning-based methods, pharmacophore-based algorithms, shape-focused techniques, molecular interaction fields (MIFs), reactivity-focused techniques, protein-ligand docking, molecular dynamics (MD) simulations, and combinations of methods. Predictive metabolism is a developing area, and there is still enormous potential for improvement. However, it is clear that the combination of rapidly increasing amounts of available ligand- and structure-related experimental data (in particular, quantitative data) with novel and diverse simulation and modeling approaches is accelerating the development of effective tools for prediction of in vivo metabolism, which is reflected by the diverse and comprehensive data sources and methods for metabolism prediction reviewed here. This review attempts to survey the range and scope of computational methods applied to metabolism prediction and also to compare and contrast their applicability and performance.

Drug metabolism in the lungs: opportunities for optimising inhaled medicines

The Roles of Pulmonary Drug-Metabolizing Enzymes and Transporters

Analyzing the metabolic fate of oral administration drugs: A review and state-of-the-art roadmap.

Drug metabolism in drug discovery and development

Computational Prediction of Metabolism: Sites, Products, SAR, P450 Enzyme Dynamics, and Mechanisms

Application of New Cellular and Microphysiological Systems to Drug Metabolism Optimization and Their Positioning Respective to In Silico Tools

Novel drug targets for asthma and COPD: lessons learned from in vitro and in vivo models

Designing Aerosol Therapies Based on the Integrated Evaluation of In Vitro, In Vivo, and In Silico Data

Role of Metabolic Reprogramming in Pulmonary Innate Immunity and Its Impact on Lung Diseases

Targeting reprogrammed metabolism as a therapeutic approach for respiratory diseases

Inhaled drug delivery: Past, present, and future

The Role of Pulmonary Drug Delivery in Modern Therapeutics: An Overview

Application of Metabolomics Across the Spectrum of Pulmonary and Critical Care Medicine

Innovative preclinical models for pulmonary drug delivery research

A mechanistic framework for a priori pharmacokinetic predictions of orally inhaled drugs

The Metabolic Potential of the Human Lung Microbiome

Pulmonary Formulations: What Remains to be Done?

Novel Approaches to Characterize Individual Drug Metabolism and Advance Precision Medicine

Pulmonary drug delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medications

Recent advances in the translation of drug metabolism and pharmacokinetics science for drug discovery and development

Antimicrobial molecules in the lung: formulation challenges and future directions for innovation